Results 51 to 60 of about 13,238 (197)

Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity

Journal of Lipid Research, 2020
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV)-2 has resulted in the death of more than 328,000 persons worldwide in the first 5 months of 2020.
Stephen L. Sturley, Tamayanthi Rajakumar, Natalie Hammond, Katsumi Higaki, Zsuzsa Márka, Szabolcs Márka, Andrew B. Munkacsi   +6 more
doaj   +1 more source

Paradoxical effect of lipid lowering therapy in homozygous familial hypercholesterolemia: Atherosclerotic plaque calcifications and increased cardiovascular events

Revista Portuguesa de Cardiologia, 2022
Tiziana Sampietro, Francesco Sbrana, Federico Bigazzi, Beatrice Dal Pino   +3 more
doaj   +1 more source

Odds ratio of dyslipidemias and elevated AIP by serum 25(OH)D levels in men and women.

, 2016
Odds ratio of dyslipidemias and elevated AIP by serum 25(OH)D levels in men and women.
Kai Feng (502124), Lili Sun (162122), Shu Jun Song (502122), Zongye Wang (3234570), Shaoyan Si (502123), Ying Wang (11406), Haiying Jia (3234567), Junli Liu (240401)   +7 more
core   +1 more source

Lipoprotein(a) in familial hypercholesterolemia: Tips from family history

Revista Portuguesa de Cardiologia, 2021
Beatrice Dal Pino, Francesco Sbrana, Michele Coceani, Federico Bigazzi, Tiziana Sampietro   +4 more
doaj   +1 more source

Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing

, 2008
Michel FarnierPoint Médical, Dijon, FranceAbstract: Mixed dyslipidemia is a common lipid disorder characterized by the presence of an atherogenic lipoprotein phenotype due to abnormalities in various atherogenic and antiatherogenic lipoproteins ...
Michel Farnier
core  

Cholesterol lipoproteins and prevalence of dyslipidemias in urban Asian Indians: A cross sectional study [PDF]

, 2014
ObjectiveTo determine levels of cholesterol lipoproteins and prevalence of dyslipidemias in urban Asian Indians.MethodsPopulation based 6123 subjects (men 3388) were evaluated.
Arvind Gupta, Krishna Kumar Sharma, Gupta, Rajeev, Prakash Deedwania, Anuj Maheshwari, Achari, Vijay, Saboo, Banshi, Rajeev Gupta, Bhansali, Anil, Balkishan Gupta, Soneil Guptha, Gupta, Balkishan, Gupta, Arvind, Singh, Jitendra, Jitendra Singh, Vijay Achari, Guptha, Soneil, Banshi Saboo, Sharma, Krishna Kumar, Maheshwari, Anuj, Deedwania, Prakash, Anil Bhansali   +21 more
core   +1 more source

Lipoprotein(a) and family history of cardiovascular disease in children with familial dyslipidemias.

, 2011
OBJECTIVE: To investigate in children and adolescents with familial dyslipidemias the association between lipoprotein(a) [Lp(a)] level and family history of cardiovascular disease (CVD), and whether this association is independent of the disturbed ...
Guardamagna O, PIRRO, Matteo, Anfossi G, Abello F   +3 more
core   +1 more source

Dyslipidemias and fibrinolysis.

, 2002
BACKGROUND: The relation between fibrinolysis and cardiovascular disease is an open debate. Fibrinolysis is related to endothelial function and presents many molecular links with platelet and coagulation activity.
BRUNI, FULVIO, PALAZZUOLI, ALBERTO, PUCCETTI, LUCA, PASTORELLI, MARCELLO, Bova G, Cercignani M, Auteri A., PASQUI, ANNA LAURA   +7 more
core   +1 more source

Impaired fibrinolytic activity is present in children with dyslipidemias

, 2004
Dyslipidemias are major risk factors for atherosclerosis and cardiovascular disease. Abnormalities of fibrinolytic and coagulation components are considered useful predictors of cardiovascular morbidity and mortality in adults.
McCrindle, BW, Albisetti, M, Chan, AKC, Andrew, M, Monagle, P, Derek Wong, Paul Monagle, Manuela Albisetti, Anthony K C Chan, Wong, D, Maureen Andrew, Brian W McCrindle   +11 more
core   +1 more source

FREQUENCY OF CO-MORBIDITIES ASSOCIATED WITH SPINAL CORD INJURY

Pakistan Armed Forces Medical Journal, 2015
Objective: To determine the frequencies of comorbidities (dyslipidemias, diabetes mellitus, and hypertension) in patients with spinal cord injury (SCI) of duration > 1 year. Study Design: Case control.
Aisha Ayyub, Atif Ahmed Khan, Rizwan Hashim, Akhtar Waheed, Salman Ali   +4 more
doaj   +2 more sources